Literature DB >> 20460367

The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis.

Dekker C Deacon1, Kathleen R Nevis, Timothy J Cashman, Yong Zhou, Long Zhao, Daniel Washko, Burcu Guner-Ataman, C Geoffrey Burns, Caroline E Burns.   

Abstract

Discovering the genetic and cellular mechanisms that drive cardiac morphogenesis remains a fundamental goal, as three-dimensional architecture greatly impacts functional capacity. During development, accurately contoured chambers balloon from a primitive tube in a process characterized by regional changes in myocardial cell size and shape. How these localized changes are achieved remains elusive. Here, we show in zebrafish that microRNA-143 (miR-143) is required for chamber morphogenesis through direct repression of adducin3 (add3), which encodes an F-actin capping protein. Knockdown of miR-143 or disruption of the miR-143-add3 interaction inhibits ventricular cardiomyocyte F-actin remodeling, which blocks their normal growth and elongation and leads to ventricular collapse and decreased contractility. Using mosaic analyses, we find that miR-143 and add3 act cell-autonomously to control F-actin dynamics and cell morphology. As proper chamber emergence relies on precise control of cytoskeletal polymerization, Add3 represents an attractive target to be fine-tuned by both uniform signals, such as miR-143, and undiscovered localized signals. Together, our data uncover the miR-143-add3 genetic pathway as essential for cardiac chamber formation and function through active adjustment of myocardial cell morphology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460367     DOI: 10.1242/dev.050526

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  44 in total

1.  No association of pri-miR-143 rs41291957 polymorphism with the risk of congenital heart disease in a Chinese population.

Authors:  Liping Yang; Xiaobo Gao; Haiyan Luo; Qiuyu Huang; Ying Wei; Guican Zhang; Guoying Huang; Dongmei Su; Liangwan Chen; Cailing Lu; Juhua Yang; Xu Ma
Journal:  Pediatr Cardiol       Date:  2014-04-22       Impact factor: 1.655

Review 2.  MicroRNAs in heart development.

Authors:  Ramón A Espinoza-Lewis; Da-Zhi Wang
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

3.  MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling.

Authors:  Vien Khach Lai; Muhammad Ashraf; Shujia Jiang; Khawaja Haider
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

4.  Whole genome expression differences in human left and right atria ascertained by RNA sequencing.

Authors:  Jeffrey Hsu; Peter Hanna; David R Van Wagoner; John Barnard; David Serre; Mina K Chung; Jonathan D Smith
Journal:  Circ Cardiovasc Genet       Date:  2012-04-03

5.  Analysis of microRNA expression during the torpor-arousal cycle of a mammalian hibernator, the 13-lined ground squirrel.

Authors:  Cheng-Wei Wu; Kyle K Biggar; Bryan E Luu; Kama E Szereszewski; Kenneth B Storey
Journal:  Physiol Genomics       Date:  2016-04-15       Impact factor: 3.107

6.  Gene locations may contribute to predicting gene regulatory relationships.

Authors:  Jun Meng; Wen-Yuan Xu; Xiao Chen; Tao Lin; Xiao-Yu Deng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

7.  Impact of miR-26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non-canonical Wnt signalling.

Authors:  Duo Wang; Chang Liu; Yumei Wang; Wenjing Wang; Kang Wang; Xiujuan Wu; Zhigang Li; Cuimei Zhao; Li Li; Luying Peng
Journal:  Cell Prolif       Date:  2017-08-15       Impact factor: 6.831

Review 8.  Uncovering the molecular and cellular mechanisms of heart development using the zebrafish.

Authors:  David Staudt; Didier Stainier
Journal:  Annu Rev Genet       Date:  2012-09-04       Impact factor: 16.830

Review 9.  Functions of microRNAs in cardiovascular biology and disease.

Authors:  Akiko Hata
Journal:  Annu Rev Physiol       Date:  2012-11-13       Impact factor: 19.318

10.  Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Saloni Singla; Natalie L Patterson; Ruby C Y Lin; Julie R McMullen
Journal:  RNA Biol       Date:  2016-04-28       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.